Getting Diagnosed with PMOS: Here’s What Tests Your Doctor Will Order

If you have spent months, or years, trying to figure out why your periods are irregular, why your skin has changed, why losing weight feels disproportionately difficult, or why your body feels somehow out of sync, you already know how exhausting that uncertainty can be. PMOS, polycystic ovary syndrome, now formally renamed polyendocrine metabolic ovarian syndrome (PMOS), affects an estimated one in ten women of reproductive age globally, yet it remains one of the most frequently missed and most poorly explained diagnoses in women’s health. Many women receive a diagnosis only after pushing through dismissiveness from multiple practitioners. Others receive a label without the underlying explanation they needed to understand what it actually means.
When women begin searching for clarity, the path typically leads through a series of tests that can feel overwhelming without context. Blood panels, hormone levels, ultrasound findings, and diagnostic criteria that vary slightly depending on which specialist you see mean the PMOS diagnostic process is genuinely complex. But understanding it in advance takes away much of its intimidation. Knowing what tests are coming and why each one is ordered puts you in a much better position to participate in your own diagnosis and ask the questions that matter.
Dr. Adam Shoman at Hackensack CMIGS approaches PMOS diagnosis with clinical precision and clear patient communication. As a board-certified gynecologist with a designated focus practice in minimally invasive gynecologic and pelvic surgery, Dr. Shoman provides comprehensive evaluation for women presenting with suspected PMOS at both the Hoboken and Hasbrouck Heights offices. His approach is rooted in evidence, including the Rotterdam criteria, the most widely accepted diagnostic framework for the condition internationally.

What Is PMOS and Why Is Diagnosis Complex?

PMOS is a hormonal and metabolic condition characterised by at least two of three features: irregular or absent ovulation, clinical or biochemical signs of elevated androgens, and polycystic-appearing ovaries on ultrasound. The Rotterdam criteria, established in 2003 by a joint ESHRE and ASRM consensus group, define these three features and remain the gold standard for clinical diagnosis internationally.

The complexity of PMOS diagnosis lies in its heterogeneity. Because only two of three features are required for diagnosis, four distinct phenotypes of PMOS exist — some with regular periods, some without polycystic ovaries, some with elevated androgens and normal cycles. This variability means there is no single test result that confirms PMOS. Rather, diagnosis involves building a picture from multiple data points and ruling out other conditions that can mimic PMOS symptoms.

Is PCOS Now Called PMOS?

Yes. In May 2026, an international consensus published in The Lancet renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, or PMOS. The change was endorsed by more than fifty academic, clinical and patient organisations after more than a decade of consultation with patients and clinicians worldwide.

The reasoning behind the change is clinical accuracy rather than branding. Most women with the condition do not have true ovarian cysts, and the old name suggested a purely gynecologic problem when the condition actually involves hormonal, metabolic, reproductive, dermatological and mental health effects together. That narrow framing contributed to delayed diagnoses, fragmented care and unnecessary stigma for decades.

For patients, nothing about diagnosis or treatment changes. The Rotterdam criteria still apply, the same blood work and ultrasound imaging are still used, and the same treatment options are still available. Both terms will remain in use for the next several years while clinical guidelines, insurance coding and medical record systems complete the transition. At Hackensack CMIGS we use both terms so that patients searching for either one find the care they need.

The Rotterdam criteria described throughout this guide are unaffected by the rename and remain the diagnostic standard.

How Is PMOS Diagnosed: The Diagnostic Process Step by Step

Step 1: Clinical History and Symptom Review

Diagnosis begins before a single test is ordered. Your physician will take a detailed history of your menstrual cycle pattern, including cycle length, regularity, and flow. They will ask about symptoms including acne, unwanted hair growth on the face or body, hair thinning or loss, weight changes, mood changes, and any previous attempts to conceive. Skin changes such as acanthosis nigricans — darkened, thickened patches of skin typically around the neck, armpits, or groin — may be noted on physical examination as an indicator of insulin resistance, which is present in 70 to 95% of PMOS patients.

Step 2: PMOS Blood Tests Explained

A blood panel is central to the PMOS diagnostic workup. The goal is to assess androgen levels, reproductive hormone function, metabolic health, and to exclude conditions that can produce similar clinical pictures.

• Testosterone (total and free): Elevated total or free testosterone is the primary marker of biochemical hyperandrogenism. Free testosterone is often more informative in the PMOS context because a significant proportion of total testosterone is bound to sex hormone-binding globulin and therefore biologically inactive. Women with PMOS frequently have reduced SHBG, increasing the fraction of free, active testosterone.
• DHEAS: This androgen is produced primarily by the adrenal glands rather than the ovaries. Significantly elevated DHEAS may point toward adrenal pathology rather than PMOS as the primary driver of androgen excess. It is included to differentiate between ovarian and adrenal sources.
• LH and FSH: In classic PMOS presentations, the LH to FSH ratio is often elevated — typically 2:1 or greater — reflecting disrupted hypothalamic-pituitary signalling and anovulation. This ratio provides supplementary information rather than diagnostic confirmation.
• Anti-Müllerian hormone (AMH): AMH is produced by the small antral follicles in the ovaries and is elevated in PMOS, reflecting the large number of small arrested follicles. AMH testing is increasingly used as a diagnostic marker and is particularly useful in patients on hormonal contraception, which can mask other hormonal abnormalities.
• Fasting glucose and fasting insulin: Insulin resistance assessment is essential in PMOS because it drives both the metabolic and reproductive manifestations of the condition. A fasting glucose-to-insulin ratio or HOMA-IR calculation quantifies insulin resistance and guides treatment decisions, particularly around lifestyle modification and medications like metformin.
• Thyroid function tests: Thyroid dysfunction — particularly hypothyroidism — can produce irregular periods, weight gain, fatigue, and changes to skin and hair that closely resemble PMOS symptoms. TSH testing is included to rule out thyroid disease as an alternative or contributing diagnosis.
• Prolactin: Elevated prolactin from a pituitary adenoma or other cause can suppress ovulation and produce menstrual irregularity. Prolactin is measured to exclude hyperprolactinaemia as an alternative explanation for anovulation.
• 17-hydroxyprogesterone: This test screens for congenital adrenal hyperplasia, a rare inherited condition that can cause androgen excess and irregular periods resembling PMOS. It is particularly important in patients with a relevant family history or very high androgen levels.

Step 3: PMOS Ultrasound Diagnosis

Transvaginal ultrasound is performed to visualise the ovaries and uterine lining. In PMOS, the ovaries may appear enlarged and contain multiple small follicles — typically 20 or more follicles measuring 2 to 9mm in diameter per ovary, or increased ovarian volume above 10ml, as defined by the updated 2018 Rotterdam threshold. They are often arranged peripherally in a pattern sometimes described as a string of pearls.

It is important to understand that polycystic-appearing ovaries are found in up to 20 to 30% of women without PMOS. Ultrasound findings alone do not confirm the diagnosis. They must be interpreted alongside hormonal and clinical data within the Rotterdam criteria framework.

Step 4: What to Expect at Your PMOS Appointment

A thorough PMOS workup typically requires at least two appointments — an initial consultation where history is taken and tests are ordered, followed by a results review where all findings are interpreted together. Some patients require additional testing depending on initial results, including a 2-hour oral glucose tolerance test if fasting glucose is borderline, or a pelvic MRI if adrenal pathology is suspected.

You can prepare for your PMOS appointment most effectively by tracking your menstrual cycles for at least three months prior, noting any associated symptoms, and bringing a list of all current medications and supplements.

After Diagnosis: What Comes Next

A PMOS diagnosis is not the end of the conversation — it is the beginning of one. Management is highly individualised and depends on the specific phenotype, the patient’s primary concerns, and their broader health context. First-line management typically includes lifestyle intervention focusing on nutrition and exercise, which has the strongest evidence base for improving both metabolic and reproductive outcomes in PMOS. Pharmacological options — including combined oral contraceptives, progesterone-only regimens, antiandrogen medications, and metformin — are selected based on specific goals and contraindications.

For women with PMOS who are trying to conceive and not responding to lifestyle measures or first-line ovulation induction, specialist fertility evaluation is appropriate. Laparoscopic ovarian drilling remains an option in selected cases, particularly for women who do not respond to medical ovulation induction. Dr. Shoman’s specialist experience in both PMOS management and minimally invasive gynecologic surgery means that patients receive continuity of care across the full spectrum of their needs.

Receiving a PMOS diagnosis can feel overwhelming, but it is also the beginning of understanding — and addressing — what has been affecting your body. An accurate diagnosis opens the door to treatment options that can meaningfully improve how you feel.

Conclusion

Getting diagnosed with PMOS involves multiple tests, some patience, and the right specialist who knows how to put the full picture together. Understanding what each test is measuring — and why — transforms what could feel like a confusing diagnostic journey into a logical, purposeful process. The Rotterdam criteria provide the framework; your symptoms, blood results, and ultrasound findings provide the detail; and your specialist provides the interpretation that turns data into a diagnosis and a direction.

If you are concerned about PMOS or have been experiencing symptoms that have gone unaddressed, a consultation with Dr. Shoman at Hackensack CMIGS will give you both the answers and the plan you need. Both the Hoboken and Hasbrouck Heights offices are available for new patient consultations.

Frequently Asked Questions

How is PMOS diagnosed?

PMOS is diagnosed using the Rotterdam criteria, which require at least two of three features: irregular or absent ovulation, clinical or biochemical signs of excess androgen, and polycystic-appearing ovaries on ultrasound. Blood tests and ultrasound are performed alongside a detailed clinical history.

What blood tests are done for PMOS?

A PMOS blood panel typically includes testosterone, DHEAS, LH, FSH, AMH, fasting glucose, fasting insulin, TSH, prolactin, and 17-hydroxyprogesterone. These tests assess androgen levels, reproductive hormones, insulin resistance, and exclude alternative diagnoses.

What does a PMOS ultrasound look like?

A PMOS ultrasound typically shows enlarged ovaries containing 20 or more small follicles arranged peripherally. Polycystic ovary morphology is one criterion under Rotterdam but can be present in women without PMOS and must be interpreted alongside hormonal findings.

What is the Rotterdam criteria for PMOS?

The Rotterdam criteria require at least two of: irregular or absent ovulation, clinical or biochemical hyperandrogenism, and polycystic ovary morphology on ultrasound. They are the most widely accepted PMOS diagnostic framework globally.

Can you have PMOS with regular periods?

Yes. One Rotterdam phenotype of PMOS involves biochemical androgen excess and polycystic ovaries without menstrual irregularity. This can present primarily with symptoms such as acne, hirsutism, or metabolic changes.

How long does PMOS diagnosis take?

The diagnostic process typically takes two to three appointments — an initial consultation, blood tests, an ultrasound, and a results review. Additional investigations may be required depending on initial findings.

What conditions can mimic PMOS?

Thyroid dysfunction, congenital adrenal hyperplasia, hyperprolactinaemia, and androgen-secreting tumours can all produce symptoms that overlap with PMOS. A comprehensive diagnostic workup includes tests to exclude these alternative diagnoses.

Does PMOS always cause infertility?

PMOS does not always cause infertility, but it is a leading cause of ovulatory infertility. Many women with PMOS conceive naturally or with minimal intervention. Those with more significant ovulatory dysfunction may benefit from ovulation induction or other fertility treatments.

What is the role of AMH in PMOS diagnosis?

Anti-Müllerian hormone is elevated in PMOS due to the increased number of small antral follicles. It is a useful supplementary marker, particularly in patients on hormonal contraception where other hormonal markers may be suppressed.

When should I see a doctor for PMOS?

If you experience irregular periods, significant acne, unwanted facial or body hair, unexplained weight changes, or difficulty conceiving, a formal evaluation for PMOS is warranted. Early diagnosis allows for earlier intervention and reduces the risk of long-term metabolic complications.

Is PCOS the same as PMOS?

Yes. PMOS, or polyendocrine metabolic ovarian syndrome, is the new official name for the condition previously called polycystic ovary syndrome. It is the same condition with the same diagnostic criteria and the same treatment options. The name was changed in May 2026 to more accurately reflect the hormonal and metabolic nature of the condition.

Do I need a new diagnosis now that PCOS is called PMOS?

No. If you have already been diagnosed with PCOS, that diagnosis stands. You do not need repeat testing or a new evaluation because of the name change. Your medical records and insurance coding may continue to say PCOS for some time while international classification systems are updated.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. PMOS diagnosis and management should be performed by a qualified healthcare professional. The Rotterdam criteria described herein reflect current international guidelines, but diagnostic approaches may vary. If you are experiencing symptoms suggestive of PMOS, please consult a licensed physician for a personalised evaluation.